Treatment of Urinary Tract Infections (UTIs)
For uncomplicated and complicated UTIs, first-line treatments include fosfomycin trometamol, nitrofurantoin, and pivmecillinam for uncomplicated cases, while fluoroquinolones, cephalosporins, and aminoglycosides are recommended for complicated infections, with treatment choices guided by local resistance patterns. 1, 2
Uncomplicated UTIs in Women
First-line Treatment Options
- Fosfomycin trometamol 3g as a single dose is highly effective with minimal resistance and low potential for collateral damage 1, 2
- Nitrofurantoin 100mg twice daily for 5 days (or macrocrystals 50-100mg four times daily) is recommended due to sustained effectiveness and low resistance rates 1, 2
- Pivmecillinam 400mg three times daily for 3-5 days is appropriate where available (primarily in European countries) 1, 2
Alternative Treatment Options
- Trimethoprim-sulfamethoxazole 160/800mg twice daily for 3 days if local resistance rates are <20% (not recommended in last trimester of pregnancy) 1, 3
- Trimethoprim 200mg twice daily for 5 days (avoid in first trimester of pregnancy) 1
- Cephalosporins (e.g., cefadroxil 500mg twice daily for 3 days) if local E. coli resistance is <20% 1, 2
- Fluoroquinolones (e.g., ciprofloxacin, levofloxacin) are effective but should be reserved for more serious infections due to their propensity for collateral damage 1, 4
Treatment Duration
- Single dose: Fosfomycin trometamol 1
- 3-day regimens: Trimethoprim-sulfamethoxazole, some cephalosporins 1
- 5-day regimens: Nitrofurantoin, trimethoprim, pivmecillinam 1, 2
Uncomplicated UTIs in Men
- Trimethoprim-sulfamethoxazole 160/800mg twice daily for 7 days is the primary treatment 1, 2
- Fluoroquinolones can be prescribed according to local susceptibility patterns 1, 2
- Longer treatment duration (7 days) is typically recommended for men 1, 3
Complicated UTIs and Pyelonephritis
Outpatient Treatment
- Oral ciprofloxacin 500mg twice daily for 7 days is appropriate when fluoroquinolone resistance is <10% 1
- Extended-release ciprofloxacin 1000mg daily for 7 days or levofloxacin 750mg daily for 5 days are effective options 1
- Consider an initial IV dose of ceftriaxone 1g or a 24-hour dose of an aminoglycoside if fluoroquinolone resistance exceeds 10% 1
- Trimethoprim-sulfamethoxazole 160/800mg twice daily for 14 days if the pathogen is known to be susceptible 1
Inpatient Treatment
- Initial IV therapy with one of the following 1:
- Fluoroquinolone (if local resistance <10%)
- Aminoglycoside with or without ampicillin
- Extended-spectrum cephalosporin or penicillin (with or without aminoglycoside)
- Carbapenem
- Treatment should be tailored based on culture and susceptibility results 1
Special Considerations
Recurrent UTIs
- Always obtain a urine culture for diagnosis 1, 2
- For women whose symptoms don't resolve by the end of treatment or recur within 2 weeks, perform urine culture and susceptibility testing 1
- Retreatment with a 7-day regimen using a different agent is recommended for recurrence 1
Antimicrobial Resistance Concerns
- Local resistance patterns should guide empiric therapy choices 1
- Escherichia coli is the predominant pathogen (75-95%) in uncomplicated UTIs 1
- Amoxicillin or ampicillin should not be used for empirical treatment due to poor efficacy and high worldwide resistance 1
- β-lactams (except pivmecillinam) generally have inferior efficacy and more adverse effects compared to other UTI antimicrobials 1, 5
Diagnostic Approach
- Diagnosis of uncomplicated cystitis can be made with high probability based on symptoms (dysuria, frequency, urgency) and absence of vaginal discharge 1
- Urine culture is recommended for suspected pyelonephritis, symptoms that don't resolve or recur within 4 weeks after treatment, women with atypical symptoms, and pregnant women 1
- For typical uncomplicated cystitis, urine analysis provides minimal increase in diagnostic accuracy 1
Treatment Algorithm
Assess if uncomplicated or complicated UTI:
- Uncomplicated: Healthy non-pregnant women with no urological abnormalities
- Complicated: Men, pregnant women, urological abnormalities, immunocompromise, or systemic symptoms
For uncomplicated UTI in women:
For uncomplicated UTI in men:
For complicated UTI/pyelonephritis:
For recurrent UTI:
Common Pitfalls and Caveats
- Fluoroquinolones should be reserved for more serious infections due to risk of collateral damage and increasing resistance 1, 5
- β-lactams (except pivmecillinam) should be used with caution due to inferior efficacy 1
- Routine post-treatment urinalysis or cultures are not indicated for asymptomatic patients 1
- Local resistance patterns significantly impact treatment success - what works in one region may not work in another 1, 6
- In elderly patients, genitourinary symptoms are not necessarily related to cystitis 1